Analystreport

Zynerba Pharmaceuticals (NASDAQ: ZYNE) was upgraded by analysts at ValuEngine from a "strong sell" rating to a "sell" rating.

Zynerba Pharmaceuticals, Inc.  (ZYNE) 
Last zynerba pharmaceuticals, inc. earnings: 3/10 06:50 am Check Earnings Report
US:NASDAQ Investor Relations: ir.zynerba.com